Navigation Links
Misonix Announces New Distribution Agreement for Belgium and Luxembourg
Date:4/1/2009

FARMINGDALE, N.Y., April 1 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year, exclusive distribution agreement with Sophysa Benelux, based in Braine l'Alleud, Belgium, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator and the BoneScalpel(TM) Ultrasonic Bone Cutter.

The agreement provides Sophysa with the rights to sell in Belgium and Luxembourg, and includes minimum purchase requirements.

Sophysa is acknowledged as a market leader and has built a reputation as a distributor of state-of-the-art medical devices and capital equipment, with special emphasis in neuro and spine surgery.

The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt(TM) bone shaving technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.

The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the potential hazards associated with rotary sharps.

"Misonix welcomes Sophysa Benelux to our growing sales and distribution organization. We know Sophysa as a first tier distributor of advanced medical equipment in the Benelux countries," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix. "Sophysa has established themselves as a quality distribution partner for successfully introducing high tech medical
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Misonix Announces New Sales Agency Agreement for Eastern Europe
2. Misonix Announces New Distribution Agreement for Israel
3. Misonix Reports Earnings and Increased Revenues for the Three and Six Months Ended December 31, 2008
4. Misonix Schedules Second Quarter Fiscal Year 2009 Financial Results Conference Call; February 9, 2009 at 4:30 P.M. Eastern
5. Misonix Announces New HIFU Distribution Agreement for Italy
6. Misonix Announces Extension and Expansion of Distribution Agreement With Mentor Corporation
7. Misonix Reports First Quarter Fiscal Year 2009 Financial Results
8. Misonix Schedules First Quarter Fiscal Year 2009 Financial Results Conference Call; November 13, 2008 at 4:30 P.M. Eastern
9. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
10. Misonix To Present at The Rodman & Renshaw 10th Annual Healthcare Conference
11. Waters Corporation Announces the Purchase of UPLC/MS Systems by the National Cancer Institute for Advanced Metabolomics Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... drug about to be tested in a clinical trial ... treatment for Alzheimer,s disease has failed to work with ... patients, according to results of a study by University ... of neuroscience affiliated with the Evelyn F. and William ... emphasized the importance of verifying promising research results before ...
(Date:5/23/2013)... 2013 The Rottenstein Law Group LLP, ... created the Tylenol Lawsuit Information Center at http://www.rotlaw.com/tylenol ... and those who are considering filing lawsuits. , ... cause severe liver damage, according to a 2009 report ... the “safety communication,” the FDA warned consumers against using ...
(Date:5/23/2013)... United States Vice President Dick Cheney served as the ... , In front of 1,500 guests yesterday at ... "I am delighted to be here to have the ... Year Award. I think it's a tremendous recognition; I ... company like this because there are obviously a great ...
(Date:5/23/2013)... Click here to read the full article: ... seeing their success develop through merger and acquisition ... to new research carried out by MaRS , the ... compiled its research into a series of articles and ... have shown the general trend that the success of ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Parker ... the rights of victims injured by defective medical devices ... Counsel Matthew J. McCauley has been appointed Co-Lead Counsel ... Mirena IUD Products Liability Litigation (Case 7:13-md-02434-CS). The Order, ... and Liaison Counsel are to submit their proposal for ...
Breaking Medicine News(10 mins):Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 4Health News:U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation 2
... , LOS ANGELES, Dec. 1 Gooooooaaaaaal! ... 2009/2010 growing season with a fresh starting lineup that expands ... an award-winning soccer player, coach and mom - will captain ... sidelines and online. Combined with league sponsorship expansion into Texas ...
... 2009 issue of the Journal of Thoracic Oncology ... metastatic lung cancer has improved over the last two decades ... an analysis of over 100,000 patients with stage IV non-small ... evaluate trends in survival between 1990 and 2005 to assess ...
... , LONDON, Dec. 1 ... devices market, particularly in the wireless assisted living devices segment. This ... this growth is rising awareness levels among an ageing population about ... elderly prefer to age at home - a trend supported by ...
... ... families prepare for and embrace caring for loved ones , ... Cincinnati, Ohio (PRWEB) December 2, 2009 -- Charles Puchta is ... , , ,“While we hope our loved ones live long, healthy and prosperous lives, the ...
... ... The American Meditation Institute (AMI) found that daily meditation, diaphragmatic breathing and yoga ... ... NY (PRWEB) December 1, 2009 –– A new retrospective, interview-based, case study found ...
... 1 "The patient will see you now." That is the ... of Minnesota,s 10,000 employees and family members today, becoming the first ... have access to Online Care Anywhere(SM). Online Care Anywhere allows patients ... onto a computer or picking up the phone. Blue Cross is ...
Cached Medicine News:Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 2Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 3Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 4Health News:Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe, Finds Frost & Sullivan 2Health News:Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe, Finds Frost & Sullivan 3Health News:Aging Expert's New Book Helps Boomers Address Challenges of Caregiving 2Health News:New American Meditation Institute Study Reports Wide-Ranging Health Benefits from Meditation and Yoga 2Health News:New American Meditation Institute Study Reports Wide-Ranging Health Benefits from Meditation and Yoga 3Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 2Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 3
(Date:5/23/2013)... -- BioElectronics Corporation (OTC Pink: BIEL), the maker of very ... panel meeting for non-thermal shortwave diathermy: The ... Meeting was held on May 21, 2013 in ... the meeting was very narrow, in that the FDA ... application of non-thermal shortwave diathermy for the treatment of ...
(Date:5/23/2013)... May 23, 2013 Halozyme Therapeutics, Inc. ... appointment of David A. Ramsay ... most recently Vice President, Corporate Development at Halozyme. ... "With his established financial management experience and ... working in our commercial group for the last ...
(Date:5/23/2013)... CARLSBAD, Calif. , May 23, 2013 Isis ... antisense therapeutics, today announced that management will present a company ... Health Care Conference on Thursday, May 30, 2013 at 8:40 ... A live audio webcast of the presentation will be ... Web site, www.isispharm.com .  A replay will be available ...
Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2
... Resources, one of the world,s leading research and ... that the increased generic erosion of key drugs ... (Abbott/Sanofi-Aventis,s Depakote/Abbott,s Depakote ER, generics), combined with projected ... will cause a precipitous $2.3 billion decline in ...
... Aug. 25 Actelion Pharmaceuticals US, Inc., today ... (FDA) has approved the brand name VELETRI® for the ... available since April 2010 as Epoprostenol for Injection for ... (PAH) and PAH associated with the scleroderma spectrum of ...
Cached Medicine Technology:Through 2019, Increased Generic Erosion of Key Agents Such as Lamictal and Depakote/Depakote ER Will Cause a Precipitous $2.3 Billion Decline in the Bipolar Disorder Drug Market 2Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension 2Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension 3Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension 4
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 7.0 mm and length 8.7 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 13.0 mm and length 15 mm....
Medicine Products: